Dipeptidyl Peptidase-4 Inhibitor Alarms: Is Heart Failure Caused by a Class Effect?

被引：0
|
作者：
Lee, Yong-ho [1 ]
机构：
[1] Yonsei Univ, Coll Med, Severance Hosp, Div Endocrinol & Metab,Dept Internal Med, 50-1 Yonsei Ro, Seoul 120752, South Korea
来源：
DIABETES & METABOLISM JOURNAL | 2015年 / 39卷 / 03期
关键词：
SITAGLIPTIN; RISK; DESIGN; TRIAL;
D O I：
10.4093/dmj.2015.39.3.204
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：204 / 206
页数：3
相关论文
共 50 条
  • [21] Stereoselective Synthesis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, (R)-Sitagliptin
    Anjibabu, Ramisetti
    Boggu, Jagan Mohan Reddy
    Shekhar, Putta
    Reddy, Basi V. Subba
    CHEMISTRYSELECT, 2016, 1 (17): : 5445 - 5447
  • [22] Do Dipeptidyl Peptidase-4 Inhibitors Increase the Risk of Heart Failure in Patients with Type 2 Diabetes?
    Hassanabad, Mortaza Fatehi
    Hassanabad, Ali Fatehi
    Fatehi, Mohammad
    CURRENT DIABETES REVIEWS, 2022, 18 (08)
  • [23] Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers
    Bergman, Arthur
    Ebel, David
    Liu, Fang
    Stone, Julie
    Wang, Amy
    Zeng, Wei
    Chen, Li
    Dilzer, Stacy
    Lasseter, Kenneth
    Herman, Gary
    Wagner, John
    Krishna, Rajesh
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2007, 28 (06) : 315 - 322
  • [24] Association between Add-On Dipeptidyl Peptidase-4 Inhibitor Therapy and Diabetic Retinopathy Progression
    Kang, Eugene Yu-Chuan
    Kang, Chunya
    Wu, Wei-Chi
    Sun, Chi-Chin
    Chen, Kuan-Jen
    Lai, Chi-Chun
    Chen, Tien-Hsing
    Hwang, Yih-Shiou
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (13)
  • [25] Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits
    Yamamoto, Toshihiko
    Shimano, Masayuki
    Inden, Yasuya
    Takefuji, Mikito
    Yanagisawa, Satoshi
    Yoshida, Naoki
    Tsuji, Yukiomi
    Hirai, Makoto
    Murohara, Toyoaki
    HEART RHYTHM, 2015, 12 (06) : 1362 - 1369
  • [26] The influence of dipeptidyl peptidase-4 inhibitor on the progression of type B intramural hematoma
    Chen, Qu
    Jiang, Dandan
    Shan, Zhonggui
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [27] Dipeptidyl peptidase-4 inhibitor-induced autoimmune diseases: Current evidence
    Roy, Ayan
    Sahoo, Jayaprakash
    Narayanan, Niya
    Merugu, Chandhana
    Kamalanathan, Sadishkumar
    Naik, Dukhabandhu
    WORLD JOURNAL OF DIABETES, 2021, 12 (09) : 1426 - 1441
  • [28] Impact of Systemic Dipeptidyl Peptidase-4 Inhibitor Use in Diabetic Macular Edema
    Rahimy, Ehsan
    Baker, Keith
    Thompson, Desmond
    Saroj, Namrata
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2020, 51 (04): : 226 - 234
  • [29] Pharmacokinetic disposition of anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in rats and dogs
    Furuta, Shinji
    Tamura, Miyuki
    Hirooka, Hiroko
    Mizuno, Yukie
    Miyoshi, Mika
    Furuta, Yoshiyuki
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2013, 38 (02) : 87 - 96
  • [30] The renoprotective effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on adenine-induced kidney disease in rats
    Abdelrahman, Aly M.
    Al Suleimani, Yousuf
    Al Za'abi, Mohammed
    Ashique, Mohammed
    Manoj, Priyadarsini
    Hartmann, Christina
    Nemmar, Abderrahim
    Schupp, Nicole
    Ali, Badreldin H.
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 667 - 676
12345